Search research articles
Contact Us
Filters
Showing results (91-100 of 261) with videos related to
Page
of 27
Sort By:
The Journal of Urology
|
November 13, 2007
Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase
David Robinson, Gabriel Sandblom, Robert Johansson, et al.
JAMA
|
June 24, 2015
Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
Stacy Loeb, Yasin Folkvaljon, Mats Lambe, et al.
International Journal of Cancer
|
September 10, 2025
Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons
E Lin, Hans Garmo, Kerri Beckmann, et al.
BMC Cancer
|
November 23, 2021
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
E Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
Breast Cancer Research and Treatment
|
June 15, 2011
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses
Voralak Vichapat, Hans Garmo, Lars Holmberg, et al.
Scandinavian Journal of Urology
|
April 13, 2016
Immediate versus delayed prostatectomy: Nationwide population-based study (.)
Stacy Loeb, Yasin Folkvaljon, David Robinson, et al.
Scientific Reports
|
December 26, 2025
Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer
Marcus Westerberg, Hans Garmo, Jesper Bonnedahl, et al.
BJU International
|
January 22, 2015
Causes of death in men with localized prostate cancer: a nationwide, population-based study
Mieke Van Hemelrijck, Yasin Folkvaljon, Jan Adolfsson, et al.
Scandinavian Journal of Urology
|
March 14, 2024
Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 - a case-control study
Mats Ahlberg, Hans Garmo, Pär Stattin, et al.
Plos One
|
November 23, 2022
Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 261) with videos related to
Sort By:
Page
of 27
The Journal of Urology
|
November 13, 2007
Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase
David Robinson, Gabriel Sandblom, Robert Johansson, et al.
JAMA
|
June 24, 2015
Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma
Stacy Loeb, Yasin Folkvaljon, Mats Lambe, et al.
International Journal of Cancer
|
September 10, 2025
Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons
E Lin, Hans Garmo, Kerri Beckmann, et al.
BMC Cancer
|
November 23, 2021
Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
E Lin, Hans Garmo, Mieke Van Hemelrijck, et al.
Breast Cancer Research and Treatment
|
June 15, 2011
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses
Voralak Vichapat, Hans Garmo, Lars Holmberg, et al.
Scandinavian Journal of Urology
|
April 13, 2016
Immediate versus delayed prostatectomy: Nationwide population-based study (.)
Stacy Loeb, Yasin Folkvaljon, David Robinson, et al.
Scientific Reports
|
December 26, 2025
Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer
Marcus Westerberg, Hans Garmo, Jesper Bonnedahl, et al.
BJU International
|
January 22, 2015
Causes of death in men with localized prostate cancer: a nationwide, population-based study
Mieke Van Hemelrijck, Yasin Folkvaljon, Jan Adolfsson, et al.
Scandinavian Journal of Urology
|
March 14, 2024
Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 - a case-control study
Mats Ahlberg, Hans Garmo, Pär Stattin, et al.
Plos One
|
November 23, 2022
Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, et al.
Page
of 27